CliffBio
small molecule

AXUMIN

FLUCICLOVINE F-18

Loss of exclusivityApril 2042latest FDA-listed patent expiry
CompanyBLUE EARTH DIAGNOSTICS LTD

Drug detail

Brand nameAXUMIN
Active ingredientFLUCICLOVINE F-18
Strength9-221mCi/ML
Dosage formSOLUTION
RouteINTRAVENOUS
ModalitySmall molecule
FDA approvalMay 2016
Marketing statusRX

Listed patents

PatentExpiresType
11980674April 2042use U-2450
10124079December 2035use U-2450
10716868December 2035use U-2450
10967077December 2035use U-2450
10933147December 2035use U-2450
9387266November 2026use U-1879
10953112November 2026use U-1879
10010632November 2026product

More from BLUE EARTH DIAGNOSTICS LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.